Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology

The Endogenous Tryptophan Metabolite and NAD+ Precursor Quinolinic Acid Confers Resistance of Gliomas to Oxidative Stress

(2013) F. Sahm et al.   CANCER RESEARCH

The Kynurenine Pathway in Brain Tumor Pathogenesis

(2012) S. Adams et al.   CANCER RESEARCH

Serum Indoleamine 2,3-Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis

(2012) Yuzo Suzuki et al.   Clinical and Vaccine Immunology

IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival

(2012) D. A. Wainwright et al.   CLINICAL CANCER RESEARCH

Quinolinic acid, the inescapable neurotoxin

(2012) Gilles J. Guillemin   FEBS Journal

Kynurenines in the mammalian brain: when physiology meets pathology

(2012) Robert Schwarcz et al.   NATURE REVIEWS NEUROSCIENCE

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

(2012) L. Pilotte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients

(2011) A.M. Myint et al.   BRAIN BEHAVIOR AND IMMUNITY

Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats

(2011) Nady Braidy et al.   FEBS Journal

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

(2011) Christiane A. Opitz et al.   NATURE

On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress

(2011) R. Lugo-Huitrón et al.   NEUROTOXICOLOGY AND TERATOLOGY

The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells

(2011) Christiane A. Opitz et al.   PLoS One

Structure, mechanism, and substrate specificity of kynureninase

(2010) Robert S. Phillips   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis

(2010) P. Sreekanthreddy et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease

(2010) D. Favre et al.   Science Translational Medicine

Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma

(2009) Hiroshi Urakawa et al.   CLINICAL & EXPERIMENTAL METASTASIS

Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase

(2009) Silvia K. Schmidt et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Age and circadian influences on picolinic acid concentrations in human cerebrospinal fluid

(2009) Sarah E. Coggan et al.   JOURNAL OF NEUROCHEMISTRY

Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy

(2009) Takeshi Miyazaki et al.   JOURNAL OF NEUROSURGERY

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-α: Course and relationship with psychiatric status

(2008) Arthur R. Van Gool et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

GPR35 is a functional receptor in rat dorsal root ganglion neurons

(2007) Hiroyuki Ohshiro et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS